Evaluation of Children with SMA Type 1 Under Treatment with Nusinersen within the Expanded Access Program in Germany.
Pechmann A, Langer T, Schorling D, Stein S, Vogt S, Schara U, Kölbel H, Schwartz O, Hahn A, Giese K, Johannsen J, Denecke J, Weiß C, Theophil M, Kirschner J.
Pechmann A, et al.
J Neuromuscul Dis. 2018;5(2):135-143. doi: 10.3233/JND-180315.
J Neuromuscul Dis. 2018.
PMID: 29689734
Free PMC article.